|
|
|
Volumn 22, Issue 1, 2001, Pages 40-45
|
|
Response to neo-adjuvant intraperitoneal and intravenous immunochemotherapy followed by interval secondary cytoreduction in stage IIIc ovarian cancer
a
a
NONE
(France)
|
|
Author keywords
Immunotherapy; Intraperitoneal neoadjuvant chemotherapy; Ovarian cancer; Stage IIIc
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
BLEOMYCIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DGZ;
DOXORUBICIN;
FLUOROURACIL;
IFOSFAMIDE;
ONDANSETRON;
PACLITAXEL;
SODIUM THIOSULFATE;
UNCLASSIFIED DRUG;
ABDOMINAL PAIN;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ARTERY THROMBOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
DRUG INDUCED DISEASE;
FEMALE;
GRANULOCYTOPENIA;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LAPAROTOMY;
NAUSEA;
NEPHROTOXICITY;
OVARY CANCER;
POSTOPERATIVE COMPLICATION;
THROMBOCYTOPENIA;
VOMITING;
ADULT;
AGED;
CARCINOMA, ENDOMETRIOID;
CYSTADENOCARCINOMA, SEROUS;
FEMALE;
HUMANS;
IMMUNOTHERAPY;
INJECTIONS, INTRAPERITONEAL;
INJECTIONS, INTRAVENOUS;
MIDDLE AGED;
NEOADJUVANT THERAPY;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
REOPERATION;
SALVAGE THERAPY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 0035079638
PISSN: 03922936
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (12)
|
|
References (29)
|
